Petros Pharmaceuticals raises $10M in registered direct offering and private placement

Petros Pharmaceuticals, Inc.

Gross proceeds of $10M from sale of 3,333,333 shares at $3.00/share; net proceeds ~$9.3M.
Issues warrants to purchase 2,500,000 shares at $3.50/share, exercisable for 5 years.
Largest shareholder among existing investors; Katalyst Securities acted as financial advisor.
Proceeds to be used for men's health platform expansion and general corporate purposes.
Closing expected on or about December 2, 2021, subject to customary conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.